12/2
01:57 pm
dvax
CDC vaccine panel set to debate hepatitis b shots, childhood immunizations [Seeking Alpha]
Low
Report
CDC vaccine panel set to debate hepatitis b shots, childhood immunizations [Seeking Alpha]
11/19
04:13 pm
dvax
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/19
04:01 pm
dvax
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
Low
Report
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
11/14
12:10 am
dvax
Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... [Yahoo! Finance]
Low
Report
Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... [Yahoo! Finance]
11/13
10:44 pm
dvax
Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts [Seeking Alpha]
Low
Report
Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts [Seeking Alpha]
11/10
08:40 am
dvax
Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market [Yahoo! Finance]
Low
Report
Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market [Yahoo! Finance]
11/6
12:10 am
dvax
Dynavax Technologies Corp (DVAX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Dynavax Technologies Corp (DVAX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/5
04:01 pm
dvax
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Medium
Report
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
11/5
04:00 pm
dvax
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Medium
Report
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
10/24
12:21 pm
dvax
Dynavax Technologies (NASDAQ:DVAX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Dynavax Technologies (NASDAQ:DVAX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
10/22
04:01 pm
dvax
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
Low
Report
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
10/21
04:06 pm
dvax
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial [Yahoo! Finance]
Low
Report
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial [Yahoo! Finance]
10/21
04:01 pm
dvax
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
Low
Report
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
10/8
12:19 pm
dvax
Dynavax Technologies (NASDAQ:DVAX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Dynavax Technologies (NASDAQ:DVAX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
9/9
01:06 pm
dvax
Shingles Vaccine Market Projected to Hit Valuation of US$ 16.80 billion by 2033 | Astute Analytica [Yahoo! Finance]
Low
Report
Shingles Vaccine Market Projected to Hit Valuation of US$ 16.80 billion by 2033 | Astute Analytica [Yahoo! Finance]